Active ingredientDihydrostreptomycin SulfateCat. No. P-D123-001CAS 5490-27-7Family · Pharmaceutical analytical standards
Dihydrostreptomycin
A semisynthetic aminoglycoside antibiotic obtained in 1946 by hydrogenating streptomycin: once used against tuberculosis, it was withdrawn from human use and today remains a veterinary antibacterial. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Besides being made in the laboratory from streptomycin, it can be produced directly by fermentation from a soil bacterium, Streptomyces humidus.
Go to the active ingredient →Active ingredientDihydrostreptomycin SulfateCat. No. P-D123-001CAS 5490-27-7
ImpurityDeoxydihydrostreptomycinCat. No. P-D123-002CAS 26086-49-7
ImpurityDihydrostreptomycin BCat. No. P-D123-003
Pharmacopoeial impurityDihydrostreptomycin Sulfate EP Impurity ACat. No. P-D123-005CAS 85-17-6No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceDihydrostreptomycin sulfate CRSEDQM code D1954000Family DihydrostreptomycinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.